Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
Bartosz Kamil SobockiKarolina Kaźmierczak-SiedleckaMarcin FolwarskiViktoria HawryłkowiczWojciech MakarewiczEwa StachowskaPublished in: Nutrients (2021)
Gut microbiota plays a significant role in the human body providing many beneficial effects on the host. However, its dysbiotic alterations may affect the tumorigenic pathway and then trigger the development of pancreatic cancer. This dysbiosis can also modulate the aggressiveness of the tumor, influencing the microenvironment. Because pancreatic cancer is still one of the most lethal cancers worldwide with surgery as the only method that influences prognosis and has curative potential, there is a need to search for other strategies which will enhance the efficiency of standard therapy and improve patients' quality of life. The administration of prebiotics, probiotics, next-generation probiotics ( Faecalibacterium prausnitzii , Akkermansia muciniphila ), synbiotics, postbiotics, and fecal microbiota transplantation through multiple mechanisms affects the composition of the gut microbiota and may restore its balance. Despite limited data, some studies indicate that the aforementioned methods may allow to achieve better effect of pancreatic cancer treatment and improve therapeutic strategies for pancreatic cancer patients.
Keyphrases
- end stage renal disease
- prognostic factors
- ejection fraction
- endothelial cells
- minimally invasive
- newly diagnosed
- stem cells
- peritoneal dialysis
- clinical practice
- coronary artery bypass
- electronic health record
- machine learning
- coronary artery disease
- patient reported outcomes
- cell therapy
- atrial fibrillation
- acute coronary syndrome
- mesenchymal stem cells
- climate change
- replacement therapy